Logo Image
|Articles|August 11, 2010

seroquelxrV2-home

When your patient on antidepressant therapy has unresolved depressive symptoms and has an inadequate response, consider SEROQUEL XR (quetiapine fumarate) as the next step.

 

SEROQUEL XR in Major Depressive Disorder (MDD)

When your patient on antidepressant therapy has unresolved depressive symptoms and has an inadequate response, consider SEROQUEL XR (quetiapine fumarate) as the next step.

  • Proven effective in MDD as adjunctive therapy to antidepressants compared to an antidepressant (AD) alone1

  • Convenient once-daily dosing1

References:

1. SEROQUEL XR Prescribing Information.

Latest CME

Jersey City Psychiatry
In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia
Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

View more
(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more
Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia
Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

View more